Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.
Soheila KazemiAlberto Domingo López-MuñozJaroslav HollýLing JinJonathan W YewdellBrian P DolanPublished in: bioRxiv : the preprint server for biology (2021)
SARS-CoV-2 is a zoonotic virus responsible for the worst global pandemic in a century. An understanding of how the virus can infect other vertebrate species is important for controlling viral spread and understanding the natural history of the virus. Here we describe a method to generate cells stably expressing equivalent levels of different ACE2 orthologs, the receptor for SARS-CoV-2, on the surface of a human cell line. We find that both binding of the viral Spike protein receptor binding domain (RBD) and infection of cells with a SARS-CoV-2 pseudovirus are proportional to ACE2 levels at the cell surface. Adaptation of this method will allow for the creation of a library of stable transfected cells expressing equivalent levels of different vertebrate ACE2 orthologs which can be repeatedly used for identifying vertebrate species which may be susceptible to infection with SARS-CoV-2 and its many variants.
Keyphrases
- sars cov
- cell surface
- induced apoptosis
- respiratory syndrome coronavirus
- cell cycle arrest
- binding protein
- angiotensin ii
- angiotensin converting enzyme
- endothelial cells
- endoplasmic reticulum stress
- oxidative stress
- cell death
- coronavirus disease
- amino acid
- signaling pathway
- protein protein
- genome wide
- pluripotent stem cells